The abstract is read at the publisher; the summary is JClub's.
Indole-3-acetic acid adjuvant enables PD-L1 antibody-expressing engineered bacteria to colonize pancreatic cancer tumors more effectively by suppressing neutrophil recruitment and clearance.
- Why it matters: Engineered bacteria are eliminated after tumor infiltration because recruited neutrophils phagocytose them, restricting bacterial spread and limiting therapeutic efficacy in pancreatic cancer.
- What they did: The study adds indole-3-acetic acid to bacterial therapy and tests synergy with gemcitabine to suppress neutrophil recruitment and eliminate existing neutrophils in pancreatic cancer mouse models.
- The result: This approach promotes intratumoral colonization, improves immune activation efficiency, reduces therapeutic bacteria clearance, and with PD-L1 antibody-expressing bacteria strengthens T-cell antitumor responses and tumor growth suppression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.